Interference of flavonoids with fluorescent intracellular probes: Methodological implications in the evaluation of the oxidative burst by flow cytometry

Cytometry Part A

Volumn 85, Issue 8, 2014, Pages 663-677

  Peluso, Ilaria ^a   Manafikhi, Husseen ^a   Reggi, Raffaella ^a   Palmery, Maura ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Flavonoids; Flow cytometry; Fluorescent intracellular probes; Oxidative burst

Indexed keywords

FLAVONOID; FLUORESCENT DYE;

CHEMISTRY; CLINICAL TRIAL (TOPIC); FLOW CYTOMETRY; HUMAN; INTRACELLULAR SPACE; PROCEDURES; RESPIRATORY BURST;

CLINICAL TRIALS AS TOPIC; FLAVONOIDS; FLOW CYTOMETRY; FLUORESCENT DYES; HUMANS; INTRACELLULAR SPACE; RESPIRATORY BURST;

EID: 84904624647     PISSN: 15524922     EISSN: 15524930     Source Type: Journal    
DOI: 10.1002/cyto.a.22490     Document Type: Review

References (185)

1. Martins PS, Brunialti MK, Martos LS, Machado FR, Assunçao MS, Blecher S, Salomao R. Expression of cell surface receptors and oxidative metabolism modulation in the clinical continuum of sepsis. Crit Care 2008;12:R25.
2. Vaitkus M, Lavinskiene S, Barkauskiene D, Bieksiene K, Jeroch J, Sakalauskas R. Reactive oxygen species in peripheral blood and sputum neutrophils during bacterial and nonbacterial acute exacerbation of chronic obstructive pulmonary disease. Inflammation 2013;36:1485-1493.
3. Sundqvist M, Wekell P, Osla V, Bylund J, Christenson K, Sävman K, Foell D, Cabral DA, Fasth A, Berg S, et al. Increased intracellular oxygen radical production in neutrophils during febrile episodes of periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis syndrome. Arthritis Rheum 2013;65:2971-2983.
4. Yamada M, Okura Y, Suzuki Y, Fukumura S, Miyazaki T, Ikeda H, Takezaki S, Kawamura N, Kobayashi I, Ariga T. Somatic mosaicism in two unrelated patients with X-linked chronic granulomatous disease characterized by the presence of a small population of normal cells. Gene 2012;497:110-115.
5. Bassiri-Jahromi S, Doostkam A. Fungal infection and increased mortality in patients with chronic granulomatous disease. J Mycol Med 2012;22:52-57.
6. Macey MG, Sangster J, Veys PA, Newland AC. Flow cytometric analysis of the functional ability of neutrophils from patients with autoimmune neutropenia. J Microsc 1990;159:277-283.
7. Shalekoff S, Tiemessen CT, Gray CM, Martin DJ. Depressed phagocytosis and oxidative burst in polymorphonuclear leukocytes from individuals with pulmonary tuberculosis with or without human immunodeficiency virus type 1 infection. Clin Diagn Lab Immunol 1998;5:41-44.
8. Ryder MI, Winkler JR, Weinreb RN. Elevated phagocytosis, oxidative burst, and F-actin formation in PMNs from individuals with intraoral manifestations of HIV infection. J Acquir Immune Defic Syndr 1988;1:346-353.
9. Ahmad M, Fleit HB, Golightly MG, La Gamma EF. In vivo effect of recombinant human granulocyte colony-stimulating factor on phagocytic function and oxidative burst activity in septic neutropenic neonates. Biol Neonate 2004;86:48-54.
10. Ferretti G, Bacchetti T, DiLudovico F, Viti B, Angeleri VA, Danni M, Provinciali L. Intracellular oxidative activity and respiratory burst of leukocytes isolated from multiple sclerosis patients. Neurochem Int 2006;48:87-92.
11. Crocker IP, Baker PN, Fletcher J. Neutrophil function in pregnancy and rheumatoid arthritis. Ann Rheum Dis 2000;59:555-564.
12. Perazzio SF, Salomão R, Silva NP, Andrade LE. Increased neutrophil oxidative burst metabolism in systemic lupus erythematosus. Lupus 2012;21:1543-1551.
13. Bertelli R, Trivelli A, Magnasco A, Cioni M, Bodria M, Carrea A, Montobbio G, Barbano G, Ghiggeri GM. Failure of regulation results in an amplified oxidation burst by neutrophils in children with primary nephritic syndrome. Clin Exp Immunol 2010;161:151-158.
14. Álvarez-Rodríguez L, López-Hoyos M, Calvo-Alén J, Aurrecoechea E, Villa I, Martínez-Taboada VM. Phagocyte dysfunction in polymyalgia rheumatica and other age-related, chronic, inflammatory conditions. J Leukoc Biol 2013;94:1071-1078.
15. Tsai JJ, Kao MH, Han SH. The respiratory burst activity of activated eosinophils in atopic asthmatics. Int Arch Allergy Immunol 1999;119:38-44.
16. Mikirova NA, Klykov AA, Jackson JA, Riordan NH. Granulocyte activity in patients with cancer and healthy subjects. Cancer Biol Ther 2008;7:1362-1367.
17. Peluso I, Morabito G, Urban L, Ioannone F, Serafini M. Oxidative stress in atherosclerosis development: the central role of LDL and oxidative burst. Endocr Metab Immune Disord Drug Targets 2012;12:351-360.
18. Serafini M, Miglio C, Peluso I, Petrosino T. Modulation of plasma non enzimatic antioxidant capacity (NEAC) by plant foods: The role of polyphenols. Curr Top Med Chem 2011;11:1821-1846.
19. Serafini M, Peluso I, Raguzzini A. Flavonoids as anti-inflammatory agents. Proc Nutr Soc 2010;69:273-278.
20. Peluso I, Miglio C, Morabito G, Ioannone F, Serafini M. Flavonoids and immune function in human: A systematic review. Crit Rev Food Sci Nutr (in press). DOI: 10.1080/10408398.2012.656770. Available online at http://www.tandfonline.com/doi/full/10.1080/10408398.2012.656770#.U3yTu02KDIU.
21. Ciz M, Denev P, Kratchanova M, Vasicek O, Ambrozova G, Lojek A. Flavonoids inhibit the respiratory burst of neutrophils in mammals. Oxid Med Cell Longev 2012;2012:181295.
22. Freitas M, Lima JL, Fernandes E. Optical probes for detection and quantification of neutrophils' oxidative burst. A review. Anal Chim Acta 2009;649:8-23.
23. Gomes A, Fernandes E, Lima JL. Fluorescence probes used for detection of reactive oxygen species. J Biochem Biophys Methods 2005;65:45-80.
24. Elbim C, Lizard G. Flow cytometric investigation of neutrophil oxidative burst and apoptosis in physiological and pathological situations. Cytometry Part A: J Int Soc Anal Cytol 2009;75A:475-481.
25. Nelson EJ, Zinkin NT, Hinkle PM. Fluorescence methods to assess multidrug resistance in individual cells. Cancer Chemother Pharmacol 1998;42:292-299.
26. Kimura Y, Kioka N, Kato H, Matsuo M, Ueda K. Modulation of drug-stimulated ATPase activity of human MDR1/P-glycoprotein by cholesterol. Biochem J 2007;401:597-605.
27. Cermak R. Effect of dietary flavonoids on pathways involved in drug metabolism. Expert Opin Drug Metab Toxicol 2008;4:17-35.
28. Brand W, Schutte ME, Williamson G, van Zanden JJ, Cnubben NH, Groten JP, van Bladeren PJ, Rietjens IM. Flavonoid-mediated inhibition of intestinal ABC transporters may affect the oral bioavailability of drugs, food-borne toxic compounds and bioactive ingredients. Biomed Pharmacother 2006;60:508-519.
29. Li P, Callery PS, Gan LS, Balani SK. Esterase inhibition by grapefruit juice flavonoids leading to a new drug interaction. Drug Metab Dispos 2007;35:1203-1208.
30. Pérez-Jiménez J, Neveu Vos F, Scalbert A. Systematic analysis of the content of 502 polyphenols in 452 foods and beverages: An application of the Phenol-Explorer database. J Agric Food Chem 2010;58:4959-4969.
31. D'Archivio M, Filesi C, Di Benedetto R, Gargiulo R, Giovannini C, Masella R. Polyphenols, dietary sources and bioavailability. Ann Ist Super Sanità 2007;43:348-361.
32. Del Rio D, Rodriguez-Mateos A, Spencer JP, Tognolini M, Borges G, Crozier A. Dietary (poly)phenolics in human health: Structures, bioavailability, and evidence of protective effects against chronic diseases. Antioxid Redox Signal 2013;18:1818-1892.
33. Simons AL, Renouf M, Murphy PA, Hendrich S. Greater apparent absorption of flavonoids is associated with lesser human fecal flavonoid disappearance rates. J Agric Food Chem 2010;58:141-147.
34. Crespy V, Morand C, Besson C, Manach C, Demigne C, Remesy C. Quercetin, but not its glycosides, is absorbed from the rat stomach. J Agric Food Chem 2002;50:618-621.
35. Talavera S, Felgines C, Texier O, Besson C, Lamaison JL, Remesy C. Anthocyanins are efficiently absorbed from the stomach in anesthetized rats. J Nutr 2003;133:4178-4182.
36. Spencer JP. Metabolism of tea flavonoids in the gastrointestinal tract. J Nutr 2003;133:3255S-3261S.
37. Tsang C, Auger C, Mullen W, Bornet A, Rouanet JM, Crozier A, Teissedre PL. The absorption, metabolism and excretion of flavan-3-ols and procyanidins following the ingestion of a grape seed extract by rats. Br J Nutr 2005;94:170-181.
38. Spencer JP, Chowrimootoo G, Choudhury R, Debnam ES, Srai SK, Rice-Evans C. The small intestine can both absorb and glucuronidate luminal flavonoids. FEBS Lett 1999;458, 224-230.
39. O'Leary KA, Day AJ, Needs PW, Mellon FA, O'Brien NM, Williamson G. Metabolism of quercetin-7- and quercetin-3-glucuronides by an in vitro hepatic model: the role of human beta-glucuronidase, sulfotransferase, catechol-O-methyltransferase and multi-resistant protein 2 (MRP2) in flavonoid metabolism. Biochem Pharmacol 2003;65:479-491.
40. Manach C, Morand C, Gil-Izquierdo A, Bouteloup-Demange C, Rémésy C. Bioavailability in humans of the flavanones hesperidin and narirutin after the ingestion of two doses of orange juice. Eur J Clin Nutr 2003;57:235-242.
41. Stockley C, Teissedre PL, Boban M, Di Lorenzo C, Restani P. Bioavailability of wine-derived phenolic compounds in humans: A review. Food Funct 2012;3:995-1007.
42. Manach C, Donovan JL. Pharmacokinetics and metabolism of dietary flavonoids in humans. Free Radic Res 2004;38:771-785.
43. Nait Chabane M, Al Ahmad A, Peluso J, Muller CD, Ubeaud G. Quercetin and naringenin transport across human intestinal Caco-2 cells. J Pharm Pharmacol 2009;61:1473-1483.
44. Passamonti S, Terdoslavich M, Franca R, Vanzo A, Tramer F, Braidot E, Petrussa E, Vianello A. Bioavailability of flavonoids: A review of their membrane transport and the function of bilitranslocase in animal and plant organisms. Curr Drug Metab 2009;10:369-394.
45. Shim CK, Cheon EP, Kang KW, Seo KS, Han HK. Inhibition effect of flavonoids on monocarboxylate transporter 1 (MCT1) in Caco-2 cells. J Pharm Pharmacol 2007;59:1515-1519.
46. Walgren RA, Karnaky KJ Jr, Lindenmayer GE, Walle T. Efflux of dietary flavonoid quercetin 4′-beta-glucoside across human intestinal Caco-2 cell monolayers by apical multidrug resistance-associated protein-2. J Pharmacol Exp Ther 2000;294:830-836.
47. Ayrton A, Morgan P. Role of transport proteins in drug absorption, distribution and excretion. Xenobiotica 2001;31:469-497.
48. Sun H, Zhang L, Chow EC, Lin G, Zuo Z, Pang KS. A catenary model to study transport and conjugation of baicalein, a bioactive flavonoid, in the Caco-2 cell monolayer: Demonstration of substrate inhibition. J Pharmacol Exp Ther 2008;326:117-126.
49. Hsiu SL, Hou YC, Wang YH, Tsao CW, Su SF, Chao PD. Quercetin significantly decreased cyclosporin oral bioavailability in pigs and rats. Life Sci 2002;72:227-235.
50. Vaidyanathan JB, Walle T. Cellular uptake and efflux of the tea flavonoid (-)epicatechin-3-gallate in the human intestinal cell line Caco-2. J Pharmacol Exp Ther 2003;307:745-752.
51. Ingelman-Sundberg M, Sim SC, Gomez A, Rodriguez-Antona C. Influence of cytochrome P450 polymorphisms on drug therapies: Pharmacogenetic, pharmacoepigenetic and clinical aspects. Pharmacol Ther 2007;116:496-526.
52. Wang D, Sadée W. Searching for polymorphisms that affect gene expression and mRNA processing: example ABCB1 (MDR1). AAPS J 2006;8:E515-E520.
53. Setchell KD, Brown NM, Lydeking-Olsen E. The clinical importance of the metabolite equol-a clue to the effectiveness of soy and its isoflavones. J Nutr 2002;132:3577-3584.
54. Cermak R, Wolffram S. The potential of flavonoids to influence drug metabolism and pharmacokinetics by local gastrointestinal mechanisms. Curr Drug Metab 2006;7:729-744.
55. Sheu MT, Liou YB, Kao YH, Lin YK, Ho HO. A quantitative structure-activity relationship for the modulation effects of flavonoids on p-glycoprotein-mediated transport. Chem Pharm Bull (Tokyo) 2010;58:1187-1194.
56. Chen C, Zhou J, Ji C. Quercetin: A potential drug to reverse multidrug resistance. Life Sci 2010;87:333-338.
57. Rodriguez-Proteau R, Mata JE, Miranda CL, Fan Y, Brown JJ, Buhler DR. Plant polyphenols and multidrug resistance: Effects of dietary flavonoids on drug transporters in Caco-2 and MDCKII-MDR1 cell transport models. Xenobiotica 2006;36:41-58.
58. Li C, Choi JS. Effects of epigallocatechin gallate on the bioavailability and pharmacokinetics of diltiazem in rats. Pharmazie 2008;63:815-818.
59. Chung JH, Choi DH, Choi JS. Effects of oral epigallocatechin gallate on the oral pharmacokinetics of verapamil in rats. Biopharm Drug Dispos 2009;30:90-93.
60. Ali MM, Agha FG, El-Sammad NM, Hassan SK. Modulation of anticancer drug-induced P-glycoprotein expression by naringin. Z Naturforsch C 2009;64:109-116.
61. Choi JS, Piao YJ, Kang KW. Effects of quercetin on the bioavailability of doxorubicin in rats: Role of CYP3A4 and P-gp inhibition by quercetin. Arch Pharm Res 2011;34:607-613.
62. Mandery K, Bujok K, Schmidt I, Keiser M, Siegmund W, Balk B, König J, Fromm MF, Glaeser H. Influence of the flavonoids apigenin, kaempferol, and quercetin on the function of organic anion transporting polypeptides 1A2 and 2B1. Biochem Pharmacol 2010;80:1746-1753.
63. Wang X, Wolkoff AW, Morris ME. Flavonoids as a novel class of human organic anion-transporting polypeptide OATP1B1 (OATP-C) modulators. Drug Metab Dispos 2005;33:1666-1672.
64. Wu CP, Calcagno AM, Hladky SB, Ambudkar SV, Barrand MA. Modulatory effects of plant phenols on human multidrug-resistance proteins 1, 4 and 5 (ABCC1, 4 and 5). FEBS J 2005;272:4725-4740.
65. Conseil G, Baubichon-Cortay H, Dayan G, Jault JM, Barron D, Di Pietro A. Flavonoids: A class of modulators with bifunctional interactions at vicinal ATP- and steroid-binding sites on mouse P-glycoprotein. Proc Natl Acad Sci USA 1998;95:9831-9836.
66. Trompier D, Baubichon-Cortay H, Chang XB, Maitrejean M, Barron D, Riordon JR, Di Pietro A. Multiple flavonoid-binding sites within multidrug resistance protein MRP1. Cell Mol Life Sci 2003;60:2164-2177.
67. Hooijberg JH, Broxterman HJ, Heijn M, Fles DL, Lankelma J, Pinedo HM. Modulation by (iso)flavonoids of the ATPase activity of the multidrug resistance protein. FEBS Lett 1997;413:344-348.
68. Zhou S, Lim LY, Chowbay B. Herbal modulation of P-glycoprotein. Drug Metab Rev 2004;36:57-104.
69. Bark H, Choi CH. PSC833, cyclosporine analogue, downregulates MDR1 expression by activating JNK/c-Jun/AP-1 and suppressing NF-kappaB. Cancer Chemother Pharmacol 2010;65:1131-1136.
70. Maher JM, Dieter MZ, Aleksunes LM, Slitt AL, Guo G, Tanaka Y, Scheffer GL, Chan JY, Manautou JE, Chen Y, et al. Oxidative and electrophilic stress induces multidrug resistance-associated protein transporters via the nuclear factor-E2-related factor-2 transcriptional pathway. Hepatology 2007;46:1597-1610.
71. Ramadass P, Meerarani P, Toborek M, Robertson LW, Hennig B. Dietary flavonoids modulate PCB-induced oxidative stress, CYP1A1 induction, and AhR-DNA binding activity in vascular endothelial cells. Toxicol Sci 2003;76:212-219.
72. Murray M. Altered CYP expression and function in response to dietary factors: Potential roles in disease pathogenesis. Curr Drug Metab 2006;7:67-81.
73. Dong H, Lin W, Wu J, Chen T. Flavonoids activate pregnane x receptor-mediated CYP3A4 gene expression by inhibiting cyclin-dependent kinases in HepG2 liver carcinoma cells. BMC Biochem 2010;11:23.
74. Walrand S, Valeix S, Rodriguez C, Ligot P, Chassagne J, Vasson MP. Flow cytometry study of polymorphonuclear neutrophil oxidative burst: A comparison of three fluorescent probes. Clin Chim Acta 2003;331:103-110.
75. Imrich A, Ning YY, Kobzik L. Intracellular oxidant production and cytokine responses in lung macrophages: evaluation of fluorescent probes. J Leukoc Biol 1999;65:499-507.
76. Kobzik L, Godleski JJ, Brain JD. Oxidative metabolism in the alveolar macrophage: Analysis by flow cytometry. J Leukoc Biol 1990;47:295-303.
77. Smith JA, Weidemann MJ. Further characterization of the neutrophil oxidative burst by flow cytometry. J Immunol Methods 1993;162:261-268.
78. Vowells SJ, Sekhsaria S, Malech HL, Shalit M, Fleisher TA. Flow cytometric analysis of the granulocyte respiratory burst: A comparison study of fluorescent probes. J Immunol Methods 1995;178:89-97.
79. van Pelt LJ, van Zwieten R, Weening RS, Roos D, Verhoeven AJ, Bolscher BG. Limitations on the use of dihydrorhodamine 123 for flow cytometric analysis of the neutrophil respiratory burst. J Immunol Methods 1996;191:187-196.
80. Bassøe CF, Li N, Ragheb K, Lawler G, Sturgis J, Robinson JP. Investigations of phagosomes, mitochondria, and acidic granules in human neutrophils using fluorescent probes. Cytometry Part B: Clin Cytom 2003;51B:21-29.
81. Bassøe CF, Smith I, Sørnes S, Halstensen A, Lehmann AK. Concurrent measurement of antigen- and antibody-dependent oxidative burst and phagocytosis in monocytes and neutrophils. Methods 2000;21:203-220.
82. Jaeger K, Scheinichen D, Heine J, Ruschulte H, Kuse E, Winkler M, Leuwer M. GM-CSF increases in vitro the respiratory burst of human neutrophils after liver transplantation. Intensive Care Med 1999;25:612-615.
83. Prince HE, Lapé-Nixon M. Influence of specimen age and anticoagulant on flow cytometric evaluation of granulocyte oxidative burst generation. J Immunol Methods 1995;188:129-138.
84. Peluso I, Morabito G, Riondino S, La Farina F, Serafini M. Lymphocytes as internal standard in oxidative burst analysis by cytometry: A new data analysis approach. J Immunol Methods 2012;379:61-65.
85. Brömme HJ, Zühlke L, Silber RE, Simm A. DCFH2 interactions with hydroxyl radicals and other oxidants--Influence of organic solvents. Exp Gerontol 2008;43:638-644.
86. Noritake M, Katsura Y, Shinomiya N, Kanatani M, Uwabe Y, Nagata N, Tsuru S. Intracellular hydrogen peroxide production by peripheral phagocytes from diabetic patients. Dissociation between polymorphonuclear leucocytes and monocytes. Clin Exp Immunol 1992;88:269-274.
87. Setsukinai K, Urano Y, Kakinuma K, Majima HJ, Nagano T. Development of novel fluorescence probes that can reliably detect reactive oxygen species and distinguish specific species. J Biol Chem 2003;278:3170-3175.
88. Sumitomo K, Shishido N, Aizawa H, Hasebe N, Kikuchi K, Nakamura M. Effects of MCI-186 upon neutrophil-derived active oxygens. Redox Rep 2007;12:189-194.
89. Kojima H, Urano Y, Kikuchi K, Higuchi T, Hirata Y, Nagano T. Fluorescent Indicators for Imaging Nitric Oxide Production. Angew Chem Int Ed Engl 1999;38:3209-3212.
90. Balcerczyk A, Soszynski M, Bartosz G. On the specificity of 4-amino-5-methylamino-2′, 7′-difluorofluorescein as a probe for nitric oxide. Free Radic Biol Med 2005;39:327-335.
91. Dickinson BC, Huynh C, Chang CJ. A palette of fluorescent probes with varying emission colors for imaging hydrogen peroxide signaling in living cells. J Am Chem Soc 2010;132:5906-5915.
92. Chen CS. Phorbol ester induces elevated oxidative activity and alkalization in a subset of lysosomes. BMC Cell Biol 2002;3:21.
93. VanderVen BC, Yates RM, Russell DG. Intraphagosomal measurement of the magnitude and duration of the oxidative burst. Traffic 2009;10:372-378.
94. Miyagawa B, Klingemann HG. Phagocytosis and burst activity of granulocytes and monocytes after stem cell transplantation. J Lab Clin Med 1997;129:634-637.
95. Palazzolo AM, Suquet C, Konkel ME, Hurst JK. Green fluorescent protein-expressing Escherichia coli as a selective probe for HOCl generation within neutrophils. Biochemistry 2005;44:6910-6919.
96. Makrigiorgos GM, Kassis AI, Mahmood A, Bump EA, Savvides P. Novel fluorescein-based flow-cytometric method for detection of lipid peroxidation. Free Radic Biol Med 1997;22:93-100.
97. Maulik G, Kassis AI, Savvides P, Makrigiorgos GM. Fluoresceinated phosphoethanolamine for flow-cytometric measurement of lipid peroxidation. Free Radic Biol Med 1998;26:645-653.
98. Model MA, KuKuruga MA, Todd RF III. A sensitive flow cytometric method for measuring the oxidative burst. J Immunol Methods 1997;202:105-111.
99. 5 8 1/5 9 1. Eur J Appl Physiol 2013;113:1241-1248.
100. Peluso I, Adorno G, Raguzzini A, Urban L, Ghiselli A, Serafini M. A new flow cytometry method to measure oxidative status: The peroxidation of leukocytes index ratio (PLIR). J Immunol Methods 2013;390:113-120.
101. Maia RC, Wagner K, Cabral RH, Rumjanek VM. Heparin reverses Rho 123 extrusion by multidrug resistant cells. Cancer Lett 1996;106:101-108.
102. Egashira M, Kawamata N, Sugimoto K, Kaneko T, Oshimi K. P-glycoprotein expression on normal and abnormally expanded natural killer cells and inhibition of P-glycoprotein function by cyclosporin A and its analogue, PSC833. Blood 1999;93:599-606.
103. Damiani D, Michieli M, Michelutti A, Geromin A, Raspadori D, Fanin R, Savignano C, Giacca M, Pileri S, Mallardi F. Expression of multidrug resistance gene (MDR-1) in human normal leukocytes. Haematologica 1993;78:12-17.
104. Shu Y, Liu H. Reversal of P-glycoprotein-mediated multidrug resistance by cholesterol derived from low density lipoprotein in a vinblastine-resistant human lymphoblastic leukemia cell line. Biochem Cell Biol 2007;85:638-646.
105. Malorni W, Lucia MB, Rainaldi G, Cauda R, Cianfriglia M, Donelli G, Ortona L. Intracellular expression of P-170 glycoprotein in peripheral blood mononuclear cell subsets from healthy donors and HIV-infected patients. Haematologica 1998;83:13-20.
106. Gupta S, Kim CH, Tsuruo T, Gollapudi S. Preferential expression and activity of multidrug resistance gene 1 product (P-glycoprotein), a functionally active efflux pump, in human CD8+ T cells: a role in cytotoxic effector function. J Clin Immunol 1992;12:451-458.
107. Tsujimura S, Saito K, Nakayamada S, Nakano K, Tsukada J, Kohno K, Tanaka Y. Transcriptional regulation of multidrug resistance-1 gene by interleukin-2 in lymphocytes. Genes Cells 2004;9:1265-1273.
108. Liptrott NJ, Penny M, Bray PG, Sathish J, Khoo SH, Back DJ, Owen A The impact of cytokines on the expression of drug transporters, cytochrome P450 enzymes and chemokine receptors in human PBMC. Br J Pharmacol 2009;156:497-508.
109. Kimura A, Ishida Y, Hayashi T, Wada T, Yokoyama H, Sugaya T, Mukaida N, Kondo T. Interferon-gamma plays protective roles in sodium arsenite-induced renal injury by up-regulating intrarenal multidrug resistance-associated protein 1 expression. Am J Pathol 2006;169:1118-1128.
110. Liu S, Beringer PM, Hidayat L, Rao AP, Louie S, Burckart GJ, Shapiro B. Probenecid, but not cystic fibrosis, alters the total and renal clearance of fexofenadine. J Clin Pharmacol 2008;48:957-965.
111. Borowski LC, Lopes RP, Gonzalez TP, Dummer LA, Chies JA, Silveira IG, Keisermann M, Bauer ME. Is steroid resistance related to multidrug resistance-I (MDR-I) in rheumatoid arthritis? Int Immunopharmacol 2007;7:836-844.
112. Rodrigues AC, Curi R, Britto LR, Rebbechi IM, Hirata MH, Bertolami MC, Bernik MM, Dorea EL, Hirata RD. Down-regulation of ABCB1 transporter by atorvastatin in a human hepatoma cell line and in human peripheral blood mononuclear cells. Biochim Biophys Acta 2006;1760:1866-1873.
113. Robey RW, Zhan Z, Piekarz RL, Kayastha GL, Fojo T, Bates SE. Increased MDR1 expression in normal and malignant peripheral blood mononuclear cells obtained from patients receiving depsipeptide (FR901228, FK228, NSC630176). Clin Cancer Res 2006;12:1547-1555.
114. Iwanaga M, Mori K, Iida T, Urata Y, Matsuo T, Yasunaga A, Shibata S, Kondo T. Nuclear factor kappa B dependent induction of gamma glutamylcysteine synthetase by ionizing radiation in T98G human glioblastoma cells. Free Radic Biol Med 1998;24:1256-1268.
115. Thevenod F, Friedmann JM, Katsen AD, Hauser IA. Up-regulation of multidrug resistance P-glycoprotein via nuclear factor-kappaB activation protects kidney proximal tubule cells from cadmium- and reactive oxygen species-induced apoptosis. J Biol Chem 2000;275:1887-1896.
116. Deng L, Lin-Lee Y, Claret F, Kuo MT. 2-Acetylaminofluorene up-regulates rat mdr1b expression through generating reactive oxygen species that activate NF-kB pathway. J Biol Chem 2001;276:413-420.
117. Bagrij T, Klokouzas A, Hladky SB, Barrand MA. Influences of glutathione on anionic substrate efflux in tumour cells expressing the multidrug resistance-associated protein, MRP1. Biochem Pharmacol 2001;62:199-206.
118. Vasconcelos FC, Cavalcanti GB Jr, Silva KL, de Meis E, Kwee JK, Rumjanek VM, Maia RC. Contrasting features of MDR phenotype in leukemias by using two fluorochromes: Implications for clinical practice. Leuk Res 2007;31:445-454.
119. Olson DP, Taylor BJ, Ivy SP. Detection of MRP functional activity: Calcein AM but not BCECF AM as a multidrug resistance-related protein (MRP1) substrate. Cytometry 2001;46:105-113.
120. Wang X, Levi AJ, Halestrap AP. Substrate and inhibitor specificities of the monocarboxylate transporters of single rat heart cells. Am J Physiol 1996;270:H476-H484.
121. Liminga G, Nygren P, Larsson R. Microfluorometric evaluation of calcein acetoxymethyl ester as a probe for P-glycoprotein-mediated resistance: effects of cyclosporin A and its nonimmunosuppressive analogue SDZ PSC 833. Exp Cell Res 1994;212:291-296.
122. Laupèze B, Amiot L, Payen L, Drénou B, Grosset JM, Lehne G, Fauchet R, Fardel O. Multidrug resistance protein (MRP) activity in normal mature leukocytes and CD34-positive hematopoietic cells from peripheral blood. Life Sci 2001;68:1323-1331.
123. Moreau A, Le Vee M, Jouan E, Parmentier Y, Fardel O. Drug transporter expression in human macrophages. Fundam Clin Pharmacol 2011;25:743-752.
124. Janneh O, Anwar T, Jungbauer C, Kopp S, Khoo SH, Back DJ, Chiba P. P-glycoprotein, multidrug resistance-associated proteins and human organic anion transporting polypeptide influence the intracellular accumulation of atazanavir. Antivir Ther 2009;14:965-974.
125. Bousquet L, Pruvost A, Guyot AC, Farinotti R, Mabondzo A. Combination of tenofovir and emtricitabine plus efavirenz: In vitro modulation of ABC transporter and intracellular drug accumulation. Antimicrob Agents Chemother 2009;53:896-902.
126. Janneh O, Hartkoorn RC, Jones E, Owen A, Ward SA, Davey R, Back DJ, Khoo SH. Cultured CD4T cells and primary human lymphocytes express hOATPs: Intracellular accumulation of saquinavir and lopinavir. Br J Pharmacol 2008;155:875-883.
127. Skazik C, Heise R, Bostanci O, Paul N, Denecke B, Joussen S, Kiehl K, Merk HF, Zwadlo-Klarwasser G, Baron JM. Differential expression of influx and efflux transport proteins in human antigen presenting cells. Exp Dermatol 2008;17:739-747.
128. Franco R, Cidlowski JA. SLCO/OATP-like transport of glutathione in FasL-induced apoptosis: glutathione efflux is coupled to an organic anion exchange and is necessary for the progression of the execution phase of apoptosis. J Biol Chem 2006;281:29542-29557.
129. Hammond CL, Marchan R, Krance SM, Ballatori N. Glutathione export during apoptosis requires functional multidrug resistance-associated proteins. J Biol Chem 2007;282:14337-14347.
130. Dinchuk JE, Kelley KA, Callahan GN. Flow cytometric analysis of transport activity in lymphocytes electroporated with a fluorescent organic anion dye. J Immunol Methods 1992;155:257-265.
131. Baus E, Urbain J, Leo O, Andris F. Flow cytometric measurement of calcium influx in murine T cell hybrids using Fluo-3 and an organic-anion transport inhibitor. J Immunol Methods 1994;173:41-47.
132. Sommer F, Bischof S, Röllinghoff M, Lohoff M. Demonstration of organic anion transport in T lymphocytes. L-lactate and fluo-3 are target molecules. J Immunol 1994;153:3523-3532.
133. Chieli E, Romiti N, Rodeiro I, Garrido G. In vitro effects of Mangifera indica and polyphenols derived on ABCB1/P-glycoprotein activity. Food Chem Toxicol 2009;47:2703-2710.
134. Hadjeri M, Barbier M, Ronot X, Mariotte AM, Boumendjel A, Boutonnat J. Modulation of P-glycoprotein-mediated multidrug resistance by flavonoid derivatives and analogues. J Med Chem 2003;46:2125-2131.
135. Kitagawa S, Nabekura T, Takahashi T, Nakamura Y, Sakamoto H, Tano H, Hirai M, Tsukahara G. Structure-activity relationships of the inhibitory effects of flavonoids on P-glycoprotein-mediated transport in KB-C2 cells. Biol Pharm Bull 2005;28:2274-2278.
136. Lim SL, Lim LY. Effects of citrus fruit juices on cytotoxicity and drug transport pathways of Caco-2 cell monolayers. Int J Pharm 2006;307:42-50.
137. Limtrakul P, Khantamat O, Pintha K. Inhibition of P-glycoprotein function and expression by kaempferol and quercetin. J Chemother 2005;17:86-95.
138. Nakatsuma A, Fukami T, Suzuki T, Furuishi T, Tomono K, Hidaka S. Effects of kaempferol on the mechanisms of drug resistance in the human glioblastoma cell line T98G. Pharmazie 2010;65:379-383.
139. Okura T, Ibe M, Umegaki K, Shinozuka K, Yamada S. Effects of dietary ingredients on function and expression of P-glycoprotein in human intestinal epithelial cells. Biol Pharm Bull 2010;33:255-259.
140. Peluso I, Romanelli L, Spagnuolo S, Manafikhi H, Palmery M. Serum depletion, multidrug resistance and fluorescent probes: Methodological implications in free radicals evaluation. J Immunol Methods 2014;405:178-180.
141. Scambia G, Ranelletti FO, Panici PB, De Vincenzo R, Bonanno G, Ferrandina G, Piantelli M, Bussa S, Rumi C, Cianfriglia M. Quercetin potentiates the effect of adriamycin in a multidrug-resistant MCF-7 human breast-cancer cell line: P-glycoprotein as a possible target. Cancer Chemother Pharmacol 1994;34:459-464.
142. van Zanden JJ, Wortelboer HM, Bijlsma S, Punt A, Usta M, Bladeren PJ, Rietjens IM, Cnubben NH. Quantitative structure activity relationship studies on the flavonoid mediated inhibition of multidrug resistance proteins 1 and 2. Biochem Pharmacol 2005;69:699-708.
143. van Zanden JJ, van der Woude H, Vaessen J, Usta M, Wortelboer HM, Cnubben NH, Rietjens IM. The effect of quercetin phase II metabolism on its MRP1 and MRP2 inhibiting potential. Biochem Pharmacol 2007;74:345-351.
144. Wenzel U, Schoberl K, Lohner K, Daniel H. Activation of mitochondrial lactate uptake by flavone induces apoptosis in human colon cancer cells. J Cell Physiol 2005;202:379-390.
145. Wesolowska O, Wiśniewski J, Sroda K, Krawczenko A, Bielawska-Pohl A, Paprocka M, Duś D, Michalak K. 8-Prenylnaringenin is an inhibitor of multidrug resistance-associated transporters, P-glycoprotein and MRP1. Eur J Pharmacol 2010;644:32-40.
146. Wong CC, Botting NP, Orfila C, Al-Maharik N, Williamson G. Flavonoid conjugates interact with organic anion transporters (OATs) and attenuate cytotoxicity of adefovir mediated by organic anion transporter 1 (OAT1/SLC22A6). Biochem Pharmacol 2011;81:942-949.
147. Chignell CF, Sik RH. A photochemical study of cells loaded with 2′, 7′- dichlorofluorescin: implications for the detection of reactive oxygen species generated during UVA irradiation. Free Radic Biol Med 2003;34:1029-1034.
148. Kachadourian R, Day BJ. Flavonoid-induced glutathione depletion: Potential implications for cancer treatment. Free Radic Biol Med 2006;41:65-76.
149. Galati G, Moridani MJ, Chan TS, O'Brien PJ. Peroxidative metabolism of apigenin and narigerin versus luteolin and quercetin: glutathione oxidation and coniugation. Free Radic Biol Med 2001;30:370-382.
150. Zhang K, Wong KP Inhibition of efflux of glutathione S-coniugates by plant polyphenols. Biochem Pharmacol 1996;52:1631-1638.
151. Leslie EM, Deeley RG, Cole SPC. Toxicological relevance of the multidrug resistance protein1 MRP1 (ABCC1) and related transporters. Toxicology 2001;167:3-23.
152. Leslie EM, Deeley RG, Cole SP. Bioflavonoid stimulation of glutathione transport by the 190-kDa multidrug resistance protein 1 (MRP1). Drug Metab Dispos 2003;31:11-15.
153. Jeong JM, Choi CH, Kang SK, Lee IH, Lee JY, Jung H. Antioxidant and chemosensitizing effects of flavonoids with hydroxy and/or methoxy groups and structure-activity relationship. J Pharm Pharm Sci 2007;10:537-546.
154. Aldini G, Yeum KJ, Carini M, Krinsky NI, Russell RM. (-)-Epigallocatechin-3-gallate prevents oxidative damage in both the aqueous and lipid compartments of human plasma. Biochem Biophys Res Commun 2003;302:409-414.
155. Aldini G, Carini M, Piccoli A, Rossoni G, Facino RM. Procyanidins from grape seeds protect endothelial cells from peroxynitrite damage and enhance endothelium-dependent relaxation in human artery: new evidences for cardio-protection. Life Sci 2003;73:2883-2898.
156. Li L, Chen CY, Chun HK, Cho SM, Park KM, Lee-Kim YC, Blumberg JB, Russell RM, Yeum KJ. A fluorometric assay to determine antioxidant activity of both hydrophilic and lipophilic components in plant foods. J Nutr Biochem 2009;20:219-226.
157. Moretti E, Mazzi L, Terzuoli G, Bonechi C, Iacoponi F, Martini S, Rossi C, Collodel G. Effect of quercetin, rutin, naringenin and epicatechin on lipid peroxidation induced in human sperm. Reprod Toxicol 2012;34:651-657.
158. Rusak G, Piantanida I, Masić L, Kapuralin K, Durgo K, Kopjar N. Spectrophotometric analysis of flavonoid-DNA interactions and DNA damaging/protecting and cytotoxic potential of flavonoids in human peripheral blood lymphocytes. Chem Biol Interact 2010;188:181-189.
159. Kanakis CD, Tarantilis PA, Polissiou MG, Diamantoglou S, Tajmir-Riahi HA. An overview of DNA and RNA bindings to antioxidant flavonoids. Cell Biochem Biophys 2007;49:29-36.
160. Webb MR, Ebeler SE. Comparative analysis of topoisomerase IB inhibition and DNA intercalation by flavonoids and similar compounds: structural determinates of activity. Biochem J 2004;384:527-541.
161. Snyder RD, Gillies PJ. Evaluation of the clastogenic, #DNA |intercalative, and topoisomerase II-interactive properties of bioflavonoids in Chinese hamster V79 cells. Environ Mol Mutagen 2002;40:266-276.
162. Jana B, Senapati S, Ghosh D, Bose D, Chattopadhyay N. Spectroscopic exploration of mode of binding of ctDNA with 3-hydroxyflavone: A contrast to the mode of binding with flavonoids having additional hydroxyl groups. J Phys Chem B 2012;116:639-645.
163. Hegde AH, Prashanth SN, Seetharamappa J. Interaction of antioxidant flavonoids with calf thymus DNA analyzed by spectroscopic and electrochemical methods. J Pharm Biomed Anal 2012;63:40-46.
164. Cho SY, Park SJ, Kwon MJ, Jeong TS, Bok SH, Choi WY, Jeong WI, Ryu SY, Do SH, Lee CS, et al. Quercetin suppresses proinflammatory cytokines production through MAP kinases andNF-kappaB pathway in lipopolysaccharide-stimulated macrophage. Mol Cell Biochem 2003;243:153-160.
165. Hämäläinen M, Nieminen R, Vuorela P, Heinonen M, Moilanen E. Anti-inflammatory effects of flavonoids: genistein, kaempferol, quercetin, and daidzein inhibit STAT-1 and NF-kappaB activations, whereas flavone, isorhamnetin, naringenin, and pelargonidin inhibit only NF-kappaB activation along with their inhibitory effect on iNOS expression and NO production in activated macrophages. Mediators Inflamm 2007;2007:45673.
166. Mamani-Matsuda M, Rambert J, Malvy D, Lejoly-Boisseau H, Daulouède S, Thiolat D, Coves S, Courtois P, Vincendeau P, Mossalayi MD. Quercetin induces apoptosis of Trypanosoma brucei gambiense and decreases the proinflammatory response of human macrophages. Antimicrob Agents Chemother 2004;48:924-929.
167. Middleton E Jr, Kandaswami C, Theoharides TC. The effects of plant flavonoids on mammalian cells: Implications for inflammation, heart disease, and cancer. Pharmacol Rev 2000;52:673-751.
168. Ramiro E, Franch A, Castellote C, Pérez-Cano F, Permanyer J, Izquierdo-Pulido M, Castell M. Flavonoids from Theobroma cacao down-regulate inflammatory mediators. J Agric Food Chem 2005:53:8506-8511.
169. Sanbongi C, Suzuki N, Sakane T. Polyphenols in chocolate, which have antioxidant activity, modulate immune functions in humans in vitro. Cell Immunol 1997;177:129-136.
170. Zielińska M, Kostrzewa A, Ignatowicz E, Budzianowski J. The flavonoids, quercetin and isorhamnetin 3-O-acylglucosides diminish neutrophil oxidative metabolism and lipid peroxidation. Acta Biochim Polym 2001;48:183-189.
171. Suri S, Taylor MA, Verity A, Tribolo S, Needs PW, Kroon PA, Hughes DA, Wilson VG. A comparative study of the effects of quercetin and its glucuronide and sulfate metabolites on human neutrophil function in vitro. Biochem Pharmacol 2008;76:645-653.
172. Fang SH, Hou YC, Chang WC, Hsiu SL, Chao PD, Chiang BL. Morin sulfates/glucuronides exert anti-inflammatory activity on activated macrophages and decreased the incidence of septic shock. Life Sci 2003;74:743-756.
173. Merfort I, Heilmann J, Weiss M, Pietta P, Gardana C. Radical scavenger activity of three flavonoid metabolites studied by inhibition of chemiluminescence in human PMNs. Planta Med 1996;62:289-292.
174. Dall'asta M, Derlindati E, Curella V, Mena P, Calani L, Ray S, Zavaroni I, Brighenti F, Del Rio D. Effects of naringenin and its phase II metabolites on in vitro human macrophage gene expression. Int J Food Sci Nutr 2013;64:843-849.
175. Castilla P, Dávalos A, Teruel JL, Cerrato F, Fernández-Lucas M, Merino JL, Sánchez-Martín CC, Ortuño J, Lasunción MA. Comparative effects of dietary supplementation with red grape juice and vitamin E on production of superoxide by circulating neutrophil NADPH oxidase in hemodialysis patients. Am J Clin Nutr 2008;87:1053-1061.
176. Ellinger S, Arendt BM, Fimmers R, Stehle P, Spengler U, Goerlich R. Bolus ingestion but not regular consumption of native or dealcoholized red wine modulates selected immunological functions of leukocytes in healthy volunteers. Ann Nutr Metab 2008;52:288-295.
177. Heinz SA, Henson DA, Nieman DC, Austin MD, Jin F. A 12-week supplementation with quercetin does not affect natural killer cell activity, granulocyte oxidative burst activity or granulocyte phagocytosis in female human subjects. Br J Nutr 2010;104:849-857.
178. Henson D, Nieman D, Davis JM, Dumke C, Gross S, Murphy A, Carmichael M, Jenkins DP, Quindry J, McAnulty S, et al. Post-160-km race decreases in granulocyte respiratory burst are not countered by quercetin ingestion. Int J Sports Med 2008;29:856-863.
179. Konrad M, Nieman DC, Henson DA, Kennerly KM, Jin F, Wallner-Liebmann SJ. The acute effect of ingesting a quercetin-based supplement on exercise-induced inflammation and immune changes in runners. Int J Sport Nutr Exerc Metab 2011;21:338-346.
180. Nieman DC, Henson DA, Gross SJ, Jenkins DP, Davis JM, Murphy EA, Carmichael MD, Dumke CL, Utter AC, McAnulty SR, et al. Quercetin reduces illness but not immune perturbations after intensive exercise. Med Sci Sports Exerc 2007;39:1561-1569.
181. Nieman DC, Henson DA, Maxwell KR, Williams AS, McAnulty SR, Jin F, Shanely RA, Lines TC. Effects of quercetin and EGCG on mitochondrial biogenesis and immunity. Med Sci Sports Exerc 2009;41:1467-75.
182. Perche O, Vergnaud-Gauduchon J, Morand C, Dubray C, Mazur A, Vasson MP. Orange juice and its major polyphenol hesperidin consumption do not induce immunomodulation in healthy well-nourished humans. Clin Nutr 2014;33:130-135.
183. Peluso I, Raguzzini A, Serafini M. Effect of flavonoids on circulating levels of TNF-α and IL-6 in humans: a systematic review and meta-analysis. Mol Nutr Food Res 2013;57:784-801.
184. Ghanim H, Sia CL, Upadhyay M, Korzeniewski K, Viswanathan P, Abuaysheh S, Mohanty P, Dandona P. Orange juice neutralizes the proinflammatory effect of a high-fat, high-carbohydrate meal and prevents endotoxin increase and Toll-like receptor expression. Am J Clin Nutr 2010;91:940-949.
185. Dresser GK, Bailey DG, Leake BF, Schwarz UI, Dawson PA, Freeman DJ, Kim RB. Fruit juices inhibit organic anion transporting polypeptide-mediated drug uptake to decrease the oral availability of fexofenadine. Clin Pharmacol Ther 2002;71:11-20.